CymaBay Therapeutics Logo Image

CymaBay Therapeutics

CymaBay Therapeutics has reached its limit for report views.

Please check back to see if CymaBay Therapeutics has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

Most Recent Annual Report

2016 Annual Report and Form 10K

CymaBay Therapeutics

CymaBay Therapeutics does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

  • CymaBay Therapeutics
  • CymaBay Therapeutics
  • CymaBay Therapeutics

About CymaBay Therapeutics

11-50 Employees
Based in Newark, California

CymaBay Therapeutics, Inc. (CBAY) is a clinical-stage biopharmaceutical company developing therapies to treat metabolic diseases with high unmet medical need, including serious rare and orphan disorders. MBX-8025 is a potent, selective, orally active PPARδ agonist.

Ticker:
CBAY
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol